Literature DB >> 32036211

The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage.

Chao Mei1, Lin Lei2, Li-Ming Tan3, Xiao-Jing Xu4, Bai-Mei He5, Chao Luo4, Ji-Ye Yin1, Xi Li1, Wei Zhang6, Hong-Hao Zhou6, Zhao-Qian Liu7.   

Abstract

Efficient DNA repair is critical for cell survival following exposure to DNA topoisomerase I (Top1) inhibitors camptothecin, a nature product from which the common chemotherapeutic drugs irinotecan and topotecan are derived. The camptothecin-derived agents exert their antitumor activities by specifically stabilizing the Top1-DNA covalent complexes (Top1cc) and blocking the DNA religation step. When exposed to these DNA damage agents, tumor cells quickly activate DNA damage response. This allows sufficient time to remove the Top1ccs and prevent tumor cells from apoptosis. Several repair pathways have been implicated in this process. One of the most relevant repair modes is DNA single strand break repair (SSBR) pathway. The expression level or mutagenesis of specific repair factors involved in SSBR pathway may play an indispensable role in individual's capacity of repairing camptothecin induced DNA damage. Therefore, understanding of the tolerance pathways counteracted to camptothecin cytotoxicity is crucial in alleviating chemotherapy resistance. This review focus on the SSBR pathway in repair camptothecin induced DNA damage, aiming to provide insights into the potential molecular determinants of camptothecin chemosensitivity.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Camptothecin; Chemoresistance; DNA repair; Genomic stability; Single strand break repair; Topoisomerase I

Mesh:

Substances:

Year:  2020        PMID: 32036211     DOI: 10.1016/j.biopha.2020.109875

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response.

Authors:  Julia M Reber; Jovana Božić-Petković; Michelle Lippmann; Marvin Mazzardo; Asisa Dilger; Rebecca Warmers; Alexander Bürkle; Aswin Mangerich
Journal:  Cell Biol Toxicol       Date:  2022-07-01       Impact factor: 6.691

Review 2.  Convection-enhanced delivery for high-grade glioma.

Authors:  Jennifer H Kang; Annick Desjardins
Journal:  Neurooncol Pract       Date:  2021-11-20

3.  Genetic interaction of the histone chaperone hip1 + with double strand break repair genes in Schizosaccharomyces pombe.

Authors:  W Miguel Disbennett; Tila M Hawk; P Daniel Rollins; Devi D Nelakurti; Bailey E Lucas; Matthew T McPherson; Hannah M Hylton; Ruben C Petreaca
Journal:  MicroPubl Biol       Date:  2022-03-28

4.  TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.

Authors:  Érica Aparecida de Oliveira; Jagat Chauhan; Julia Rezende da Silva; Larissa Anastacio da Costa Carvalho; Diogo Dias; Danielle Gonçalves de Carvalho; Luis Roberto Masao Watanabe; Vito W Rebecca; Gordon Mills; Yiling Lu; Aloisio Souza Felipe da Silva; Márcia Edilaine Lopes Consolaro; Meenhard Herlyn; Patricia A Possik; Colin R Goding; Silvya Stuchi Maria-Engler
Journal:  Pharmacol Res       Date:  2021-09-22       Impact factor: 7.658

Review 5.  Topoisomerase-Mediated DNA Damage in Neurological Disorders.

Authors:  Morgan Crewe; Ram Madabhushi
Journal:  Front Aging Neurosci       Date:  2021-11-25       Impact factor: 5.750

6.  eIF3a-PPP2R5A-mediated ATM/ATR dephosphorylation is essential for irinotecan-induced DNA damage response.

Authors:  Chao Mei; Ze-En Sun; Li-Ming Tan; Jian-Ping Gong; Xi Li; Zhao-Qian Liu
Journal:  Cell Prolif       Date:  2022-02-21       Impact factor: 8.755

Review 7.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09

Review 8.  Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience.

Authors:  Pavan S Upadhyayula; Eleonora F Spinazzi; Michael G Argenziano; Peter Canoll; Jeffrey N Bruce
Journal:  Pharmaceutics       Date:  2020-12-30       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.